The results of the univariate analysis indicated that both the expression level of TNFAIP3 and the TNM stage independently predicted prognosis in ESCC patients (Table 1), which further supports the potential of targeting TNFAIP3 expression as a promising strategy for treating these patients. Here, TNFAIP3 is linked to esophageal squamous cell carcinoma.